Alcon Inc (ALC)
78.74
-0.10
(-0.13%)
USD |
NYSE |
Apr 26, 12:36
Alcon Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 90.00M |
| September 30, 2022 | 172.00M |
| June 30, 2022 | 274.00M |
| March 31, 2022 | -64.00M |
| December 31, 2021 | 42.00M |
| September 30, 2021 | 214.00M |
| June 30, 2021 | -125.00M |
| March 31, 2021 | 34.00M |
| Date | Value |
|---|---|
| December 31, 2020 | 199.00M |
| September 30, 2020 | 199.00M |
| June 30, 2020 | -68.00M |
| March 31, 2020 | -74.00M |
| December 31, 2019 | 75.00M |
| September 30, 2019 | 129.00M |
| June 30, 2019 | 145.00M |
| March 31, 2019 | -105.00M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-125.00M
Minimum
Jun 2021
274.00M
Maximum
Jun 2022
82.80M
Average
90.00M
Median
Dec 2022
Free Cash Flow (Quarterly) Benchmarks
| AC Immune SA | -17.38M |
| CRISPR Therapeutics AG | -96.81M |
| Addex Therapeutics Ltd | -0.5575M |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | -17.34M |